Juan Sanabria
Stock Analyst at BMO Capital
(2.31)
# 2,366
Out of 4,814 analysts
90
Total ratings
55.32%
Success rate
3.58%
Average return
Main Sectors:
Stocks Rated by Juan Sanabria
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ELS Equity LifeStyle Properties | Upgrades: Outperform | $78 | $65.31 | +19.43% | 1 | Apr 4, 2025 | |
SKT Tanger | Initiates: Market Perform | $36 | $32.41 | +11.08% | 1 | Jan 28, 2025 | |
CTRE CareTrust REIT | Downgrades: Market Perform | $34 → $32 | $28.75 | +11.32% | 3 | Dec 9, 2024 | |
OHI Omega Healthcare Investors | Upgrades: Outperform | $45 | $38.54 | +16.76% | 3 | Dec 9, 2024 | |
BRX Brixmor Property Group | Upgrades: Outperform | $30 → $33 | $25.51 | +29.36% | 2 | Dec 6, 2024 | |
CUBE CubeSmart | Downgrades: Market Perform | $50 → $47 | $39.50 | +18.99% | 11 | May 29, 2024 | |
PSA Public Storage | Maintains: Outperform | $325 → $330 | $296.00 | +11.49% | 3 | Mar 19, 2024 | |
NHI National Health Investors | Upgrades: Outperform | $67 | $75.62 | -11.40% | 1 | Mar 12, 2024 | |
PECO Phillips Edison & Company | Maintains: Market Perform | $37 → $40 | $36.20 | +10.50% | 2 | Dec 15, 2023 | |
HR Healthcare Realty Trust | Maintains: Market Perform | $20 → $17 | $15.98 | +6.38% | 1 | Oct 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $38 | $35.75 | +6.29% | 5 | Dec 16, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $45 | $33.62 | +33.87% | 1 | Apr 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $46 | $36.92 | +24.59% | 1 | Apr 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $70 → $75 | $36.72 | +104.25% | 3 | Dec 13, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $80 → $82 | $71.77 | +14.25% | 1 | Dec 1, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $145 | $93.62 | +54.88% | 1 | Dec 1, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $100 | $147.27 | -32.10% | 3 | Aug 26, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | $60 | $67.75 | -11.44% | 4 | Aug 26, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $20 → $21 | $18.14 | +15.77% | 8 | May 21, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $160 | $141.00 | +13.48% | 7 | May 14, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $7.35 | +117.69% | 1 | Apr 16, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $120 → $125 | $150.39 | -16.88% | 1 | Apr 15, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $266 → $273 | $275.40 | -0.87% | 5 | Nov 16, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $7.83 | - | 3 | May 18, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $318.01 | - | 6 | Mar 1, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $42 | $41.28 | +1.76% | 4 | Jun 8, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $197 → $198 | $200.06 | -1.03% | 4 | Jun 8, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $103 → $104 | $112.17 | -7.28% | 1 | Jun 8, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $74 → $76 | $68.15 | +11.52% | 2 | Jun 8, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $18.75 | -3.97% | 1 | Mar 8, 2018 |
Equity LifeStyle Properties
Apr 4, 2025
Upgrades: Outperform
Price Target: $78
Current: $65.31
Upside: +19.43%
Tanger
Jan 28, 2025
Initiates: Market Perform
Price Target: $36
Current: $32.41
Upside: +11.08%
CareTrust REIT
Dec 9, 2024
Downgrades: Market Perform
Price Target: $34 → $32
Current: $28.75
Upside: +11.32%
Omega Healthcare Investors
Dec 9, 2024
Upgrades: Outperform
Price Target: $45
Current: $38.54
Upside: +16.76%
Brixmor Property Group
Dec 6, 2024
Upgrades: Outperform
Price Target: $30 → $33
Current: $25.51
Upside: +29.36%
CubeSmart
May 29, 2024
Downgrades: Market Perform
Price Target: $50 → $47
Current: $39.50
Upside: +18.99%
Public Storage
Mar 19, 2024
Maintains: Outperform
Price Target: $325 → $330
Current: $296.00
Upside: +11.49%
National Health Investors
Mar 12, 2024
Upgrades: Outperform
Price Target: $67
Current: $75.62
Upside: -11.40%
Phillips Edison & Company
Dec 15, 2023
Maintains: Market Perform
Price Target: $37 → $40
Current: $36.20
Upside: +10.50%
Healthcare Realty Trust
Oct 6, 2023
Maintains: Market Perform
Price Target: $20 → $17
Current: $15.98
Upside: +6.38%
Dec 16, 2022
Downgrades: Underperform
Price Target: $38
Current: $35.75
Upside: +6.29%
Apr 14, 2022
Initiates: Market Perform
Price Target: $45
Current: $33.62
Upside: +33.87%
Apr 14, 2022
Initiates: Outperform
Price Target: $46
Current: $36.92
Upside: +24.59%
Dec 13, 2021
Upgrades: Outperform
Price Target: $70 → $75
Current: $36.72
Upside: +104.25%
Dec 1, 2021
Upgrades: Outperform
Price Target: $80 → $82
Current: $71.77
Upside: +14.25%
Dec 1, 2021
Upgrades: Outperform
Price Target: $145
Current: $93.62
Upside: +54.88%
Aug 26, 2021
Upgrades: Outperform
Price Target: $100
Current: $147.27
Upside: -32.10%
Aug 26, 2021
Upgrades: Market Perform
Price Target: $60
Current: $67.75
Upside: -11.44%
May 21, 2021
Upgrades: Outperform
Price Target: $20 → $21
Current: $18.14
Upside: +15.77%
May 14, 2021
Downgrades: Market Perform
Price Target: $160
Current: $141.00
Upside: +13.48%
Apr 16, 2021
Initiates: Outperform
Price Target: $16
Current: $7.35
Upside: +117.69%
Apr 15, 2021
Maintains: Market Perform
Price Target: $120 → $125
Current: $150.39
Upside: -16.88%
Nov 16, 2020
Maintains: Buy
Price Target: $266 → $273
Current: $275.40
Upside: -0.87%
May 18, 2020
Downgrades: Underperform
Price Target: n/a
Current: $7.83
Upside: -
Mar 1, 2019
Downgrades: Neutral
Price Target: n/a
Current: $318.01
Upside: -
Jun 8, 2018
Maintains: Buy
Price Target: $41 → $42
Current: $41.28
Upside: +1.76%
Jun 8, 2018
Maintains: Neutral
Price Target: $197 → $198
Current: $200.06
Upside: -1.03%
Jun 8, 2018
Maintains: Buy
Price Target: $103 → $104
Current: $112.17
Upside: -7.28%
Jun 8, 2018
Maintains: Buy
Price Target: $74 → $76
Current: $68.15
Upside: +11.52%
Mar 8, 2018
Maintains: Buy
Price Target: $20 → $18
Current: $18.75
Upside: -3.97%